L. rhamnosus GR-1 and L. reuteri RC-14 are the two most clinically studied strains for women's vaginal and urinary health, with 25+ years of published research. 5 Billion CFU each is the exact dose used in clinical trials. This is evidence-based women's probiotic health at its finest. Simple, targeted, proven.
The set is generated, never written by the brand.
Jarrow Formulas Fem Dophilus: the formulation holds up. Lead: Lactobacillus rhamnosus GR-1 at 5 Billion CFU. L. Clinical dose on the primary, and the panel holds together.
GR-1 and RC-14 have 90+ published studies over 25+ years for women's vaginal health. Clinically proven to reduce UTIs, yeast infections, and BV recurrence. No other women's probiotic has even 10% of this evidence base. The gold standard.
2 of 2 shown

